WallStreetZenWallStreetZen

NASDAQ: BCRX
Biocryst Pharmaceuticals Inc Stock Ownership - Who owns Biocryst Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biocryst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alane P. BarnesChief Legal Officer2025-12-0319,770$7.65
$151.24kSell
Alane P. BarnesChief Legal Officer2025-12-0250,906$7.21
$367.24kSell
Alane P. BarnesChief Legal Officer2025-12-0191,004$3.22
$293.03kBuy
Alane P. BarnesChief Legal Officer2025-12-0191,004$7.10
$646.49kSell
Vincent MilanoDirector2025-11-28783$7.18
$5.62kBuy
Amy E. McKeeDirector2025-11-28783$7.18
$5.62kBuy
Steven FrankDirector2025-11-281,566$7.18
$11.24kBuy
Machelle SandersDirector2025-11-139,600$7.14
$68.54kSell
Vincent MilanoDirector2025-08-29676$8.31
$5.62kBuy
Steven FrankDirector2025-08-291,353$8.31
$11.24kBuy

1 of 3

BCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCRX insiders and whales buy or sell their stock.

BCRX Shareholders

What type of owners hold Biocryst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc10.35%21,790,881$164.96MInstitution
Baker Bros Advisors LP10.23%21,543,334$163.08MInsider
Blackrock Inc10.09%21,245,876$160.83MInstitution
Deerfield Management Company LP5.78%12,169,000$92.12MInstitution
State Street Corp4.66%9,807,438$74.24MInstitution
Kynam Capital Management LP4.46%9,390,270$71.08MInstitution
Ubs Group Ag2.83%5,967,737$45.18MInstitution
Alkeon Capital Management LLC2.60%5,464,021$41.36MInstitution
Arrowstreet Capital Limited Partnership2.48%5,225,986$39.56MInstitution
Morgan Stanley2.47%5,202,959$39.39MInstitution

1 of 3

BCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCRX83.90%16.10%Net SellingNet Selling
AGIO76.65%23.35%Net SellingNet Selling
TSHA89.69%10.31%Net BuyingNet Buying
PHVS89.05%0.00%
ATAI12.02%25.40%Net Buying
View Top Biotech Stocks

Biocryst Pharmaceuticals Stock Ownership FAQ

Who owns Biocryst Pharmaceuticals?

Biocryst Pharmaceuticals (NASDAQ: BCRX) is owned by 92.21% institutional shareholders, 17.70% Biocryst Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Biocryst Pharmaceuticals shareholder, owning 21.54M shares representing 10.23% of the company. Baker Bros Advisors LP's Biocryst Pharmaceuticals shares are currently valued at $163.08M.

If you're new to stock investing, here's how to buy Biocryst Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.